Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Toubert

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Current Research in Translational Medicine|June 19, 2016
Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseasesL C M Arruda, E Clave, H Moins-Teisserenc, et al.
Bone Marrow Transplantation|August 26, 1998
Characterisation of the roles of CD95 and CD95 ligand in cord bloodB Drénou, C Choqueux, A El Ghalbzouri, et al.
The Journal of Clinical Investigation|December 15, 1996
Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathiesF Boisgérault, V Tieng, M C Stolzenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2000
Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8S Fournel, M Aguerre-Girr, X Huc, et al.
Tissue Antigens|December 24, 1998
Identification of a novel HLA-B*51 variant: HLA-B*5112R Tamouza, C J Visser, N El Kassar, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1996
Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathyF Boisgerault, I Khalil, V Tieng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1988
Hybrid genes between HLA-A2 and HLA-A3 constructed by in vivo recombination allow mapping of HLA-A2 and HLA-A3 polymorphic antigenic determinantsJ Sire, G Chimini, J Boretto, et al.
Bone Marrow Transplantation|August 26, 1998
Effects of superantigenic stimulation on the cord blood alphabeta T cell repertoireA Toubert, C Douay, N Chalumeau, et al.
Infection and Immunity|August 26, 1998
Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneriF Boisgérault, J Mounier, V Tieng, et al.
Arthritis and Rheumatism|February 1, 1997
Weak association between HLA-B27 and the spondylarthropathies in LebanonH Awadia, R Baddoura, R Naman, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Current Research in Translational Medicine|June 19, 2016
Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseasesL C M Arruda, E Clave, H Moins-Teisserenc, et al.
Bone Marrow Transplantation|August 26, 1998
Characterisation of the roles of CD95 and CD95 ligand in cord bloodB Drénou, C Choqueux, A El Ghalbzouri, et al.
The Journal of Clinical Investigation|December 15, 1996
Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathiesF Boisgérault, V Tieng, M C Stolzenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2000
Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8S Fournel, M Aguerre-Girr, X Huc, et al.
Tissue Antigens|December 24, 1998
Identification of a novel HLA-B*51 variant: HLA-B*5112R Tamouza, C J Visser, N El Kassar, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1996
Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathyF Boisgerault, I Khalil, V Tieng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1988
Hybrid genes between HLA-A2 and HLA-A3 constructed by in vivo recombination allow mapping of HLA-A2 and HLA-A3 polymorphic antigenic determinantsJ Sire, G Chimini, J Boretto, et al.
Bone Marrow Transplantation|August 26, 1998
Effects of superantigenic stimulation on the cord blood alphabeta T cell repertoireA Toubert, C Douay, N Chalumeau, et al.
Infection and Immunity|August 26, 1998
Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneriF Boisgérault, J Mounier, V Tieng, et al.
Arthritis and Rheumatism|February 1, 1997
Weak association between HLA-B27 and the spondylarthropathies in LebanonH Awadia, R Baddoura, R Naman, et al.
Pageof 9